FLUVOXAMINE MALEATE by Teva is neurons. Approved for obsessions, compulsions in patients with obsessive compulsive disorder (ocd), defined in dsm-iii-r and 1 more indications. First approved in 2002.
Drug data last refreshed 20h ago
neurons. Fluvoxamine has been shown to be a potent inhibitor of the serotonin reuptake transporter in preclinical studies, both in vitro and in vivo .
Worked on FLUVOXAMINE MALEATE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.